{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:36:58Z","timestamp":1774114618082,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010983","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000}}],"reference-count":302,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010983.pub2","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T11:16:59Z","timestamp":1447845419000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation"],"prefix":"10.1002","volume":"2015","author":[{"given":"Lise J","family":"Estcourt","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J","family":"Stanworth","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust and the University of Oxford; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital, Headley Way Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford Oxfordshire UK OX2 6UD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialena","family":"Trivella","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford Oxfordshire UK OX2 6UD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F","family":"Murphy","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals and the University of Oxford; NHS Blood and Transplant; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital Headington Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"key":"10.1002\/14651858.CD010983.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomised trial of a prophylactic platelet transfusion trigger of 10 x 109 per L versus 30 x 109 per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"issue":"Abstract","key":"10.1002\/14651858.CD010983.pub2-BIB0002|cit2","first-page":"192a","article-title":"Randomized evaluation of the optimal platelet count for prophylactic platelet transfusions in patients undergoing induction therapy for acute leukaemia (American Society of Hematology 35th Annual Meeting)","volume":"82","author":"Heckman","year":"1993","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukaemia: 10 x 109\/L versus 20 x 109\/L","volume":"15","author":"Heckman","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomised trials of platelet transfusion triggers","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"},{"issue":"Supplement","key":"10.1002\/14651858.CD010983.pub2-BIB0005|cit5","first-page":"768","article-title":"The platelet transfusion trigger trial (PTTT): A multivariate analysis of risk factors for major bleeding in acute myeloid leukaemia (AML)","volume":"78","author":"Finazzi G for the GIMEMA Group","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0006|cit6","first-page":"443a","article-title":"Interim report from the platelet transfusion trigger trial (PTTT): a prospective controlled study on bleeding risk in acute myeloid leukaemia (AML) patients randomized to be transfused at \u226410 versus \u226420 x 109\/L platelets","volume":"88","author":"GIMEMA Group","year":"1996","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1537-2995.2006.00822.x","article-title":"A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukaemia","volume":"46","author":"Heddle","year":"2006","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukaemia","volume":"337","author":"Rebulla","year":"1997","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0009|cit9","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukaemia","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000441-198603000-00001","article-title":"Bleeding due to thrombocytopenia in acute leukaemias and reevaluation of the prophylactic platelet transfusion policy","volume":"291","author":"Aderka","year":"1986","journal-title":"American Journal of the Medical Sciences"},{"issue":"9S","key":"10.1002\/14651858.CD010983.pub2-BIB0011|cit11","first-page":"117A","article-title":"Clinical study in pediatric hemato-oncology patients: efficacy of pathogen inactivated platelets versus apheresis platelets","volume":"46","author":"Agliastro","year":"2006","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1423-0410.2007.00917.x","article-title":"Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy","volume":"93","author":"Akk\u00f6k","year":"2007","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-3148.1997.d01-73.x","article-title":"A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions","volume":"7","author":"Anderson","year":"1997","journal-title":"Transfusion Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tracli.2009.04.001","article-title":"Platelet transfusion: products, indications, dose, threshold and efficacy","volume":"16","author":"Andreu","year":"2009","journal-title":"Transfusion Clinique Et Biologique"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(05)81705-6","article-title":"A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants","volume":"123","author":"Andrew","year":"1993","journal-title":"Journal of Pediatrics"},{"issue":"supplement","key":"10.1002\/14651858.CD010983.pub2-BIB0016|cit16","first-page":"1A","article-title":"A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets","volume":"44","author":"Arnold","year":"2004","journal-title":"Transfusion"},{"issue":"8","key":"10.1002\/14651858.CD010983.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1537-2995.2006.00892.x","article-title":"Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses","volume":"46","author":"Arnold","year":"2006","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010983.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.critrevonc.2003.04.001","article-title":"Thrombocytopenia and hemorrhagic risk in cancer patients","volume":"48","author":"Avvisati","year":"2003","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0019|cit19","first-page":"437","article-title":"A multi-centre clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor","volume":"26","author":"Bai","year":"2004","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao Acta Academiae Medicinae Sinicae"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1040-8428(01)00182-2","article-title":"What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?","volume":"42","author":"Benjamin","year":"2002","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0021|cit21","unstructured":"Bentley M Taylor K Kelly C Taylor D Leach B Rodwell R Thrombopoietin derived autologous cryopreserved platelet support for peripheral blood progenitor cell transplantation Haematology Society of Australia and New Zealand Annual Scientific Meeting Perth"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0022|cit22","first-page":"198","article-title":"New strategies for the optimal use of platelet transfusions","volume":"2008","author":"Blajchman","year":"2008","journal-title":"Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program"},{"issue":"9S","key":"10.1002\/14651858.CD010983.pub2-BIB0023|cit23","first-page":"5S","article-title":"Platelet transfusion and clinical outcome in acute leukemia in adults","volume":"42","author":"Blumberg","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Blumberg N Heal JM Rowe JM A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] BMC Blood Disorders 2004 10.1186\/1471-2326-4-6","DOI":"10.1186\/1471-2326-4-6"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0025|cit25","first-page":"215A","article-title":"A prospective randomised study of platelet concentrates irradiated with ultraviolet (UV)-B light in patients with high grade haematological malignancy","volume":"80","author":"Blundell","year":"1992","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1537-2995.1996.36496226140.x","article-title":"A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy","volume":"36","author":"Blundell","year":"1996","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1537-2995.2010.02688.x","article-title":"An update on platelet transfusion in hematooncology supportive care","volume":"50","author":"Buhrkuhl","year":"2010","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.2002.03616.x","article-title":"The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy","volume":"118","author":"Callow","year":"2002","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1537-2995.2007.01090.x","article-title":"Evaluation of platelet transfusion triggers in a tertiary-care hospital","volume":"47","author":"Cameron","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2141.1990.tb04356.x","article-title":"Transfusion of ABO-mismatched platelets leads to early platelet refractoriness","volume":"75","author":"Carr","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2044.2004.03711.x","article-title":"The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review","volume":"59","author":"Casbard","year":"2004","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1537-2995.2005.04286.x","article-title":"Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy","volume":"45","author":"Chaoui","year":"2005","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0033|cit33","first-page":"249","article-title":"'Bleeding' and 'transfusion support' in acute myeloid leukemia patients: the challenges","volume":"28","author":"Chaurasia","year":"2012","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1537-2995.2006.01137.x","article-title":"Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials","volume":"47","author":"Cid","year":"2007","journal-title":"Transfusion"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD010983.pub2-BIB0035|cit35","first-page":"178","article-title":"Intercept platelet concentrates (IPC) are effective and safe for support of multiple cycles of thrombocytopenia: the eurosprite phase III trial","volume":"2","author":"Corash","year":"2001","journal-title":"Hematology Journal"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1537-2995.2002.00070.x","article-title":"Platelet transfusions in children: results of a randomised prospective cross-over trial of plasma removal and a prospective audit of WBC reduction","volume":"42","author":"Couban","year":"2002","journal-title":"Transfusion"},{"issue":"12","key":"10.1002\/14651858.CD010983.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1704675","article-title":"Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma","volume":"34","author":"Decaudin","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1537-2995.2000.40040398.x","article-title":"Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study","volume":"40","author":"Wildt-Eggen","year":"2000","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1423-0410.2009.01197.x","article-title":"A randomised study of buffy coat platelets in platelet additive solution 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic cell transplant recipients","volume":"97","author":"Diedrich","year":"2009","journal-title":"Vox Sanguinis"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010983.pub2-BIB0040|cit40","first-page":"Abstract","article-title":"A randomized study in allogeneic haematopoietic stem cell transplant recipients comparing prophylactic transfusion of buffy coat platelets stored for 1-5 vs. 6-7 days","volume":"95","author":"Diedrich","year":"2008","journal-title":"Vox Sanguinis"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0041|cit41","first-page":"47","article-title":"Platelet transfusion support during bone marrow transplantation. Comparative study between the use of HLA platelet apheresis and random platelet apheresis","volume":"43","author":"Pietro","year":"1998","journal-title":"Trasfusione del Sangue"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0042|cit42","first-page":"1241","article-title":"A randomized controlled trial comparing autologous radiolabeled in vivo platelet(plt) recoveries and survivals of 7-day-stored plt-rich plasma and buffy coat plts from the same subjects","volume":"6","author":"Dumont","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0043|cit43","first-page":"324","article-title":"Predicting hemorrhage using preoperative coagulation screening assays","volume":"3","author":"Dzik","year":"2004","journal-title":"Current Hematology Reports"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1537-2995.2007.01248.x","article-title":"Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: The American Red Cross Experience (2004-2006)","volume":"47","author":"Eder","year":"2007","journal-title":"Transfusion"},{"issue":"12","key":"10.1002\/14651858.CD010983.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/cncr.10603","article-title":"The bleeding risk index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors","volume":"94","author":"Elting","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cncr.11195","article-title":"Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors","volume":"97","author":"Elting","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/gyno.1995.0006","article-title":"Conservative management of chemotherapy-induced thrombocytopenia in women with gynecological cancers","volume":"59","author":"Fanning","year":"1995","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0048|cit48","first-page":"233","article-title":"Homologous platelet concentrates: products available and utilisation rules in oncology and haematology","volume":"10","author":"Follea","year":"2004","journal-title":"Hematologie"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfusion Medicine Reviews"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD010983.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1097\/01.CCM.0000214288.88308.26","article-title":"Fresh frozen plasma and platelet transfusion for non-bleeding patients in the intensive care unit: Benefit or harm?","volume":"35","author":"Gajic","year":"2006","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1537-2995.2009.02253.x","article-title":"Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit","volume":"49","author":"Gerday","year":"2009","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0052|cit52","first-page":"931","article-title":"Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution","volume":"18","author":"Gil-Fernandez","year":"1996","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V62.2.473.473","article-title":"Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia","volume":"62","author":"Gm\u00fcr","year":"1983","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gm\u00fcr","year":"1991","journal-title":"The Lancet"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood.V98.5.1346","article-title":"Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin","volume":"98","author":"Goodnough","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0056|cit56","first-page":"1558","article-title":"Issues in the management of cancer-related thrombocytopenia","volume":"16","author":"Goodnough","year":"2002","journal-title":"Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atc.2004.07.004","article-title":"Risks of blood transfusion","volume":"23","author":"Goodnough","year":"2005","journal-title":"Anesthesiology Clinics of North America"},{"issue":"S2","key":"10.1002\/14651858.CD010983.pub2-BIB0058|cit58","first-page":"20A","article-title":"Clinical evaluation of Mirasol PRT treated apheresis platelets in thrombocytopenic patients","volume":"48","author":"Goodrich","year":"2008","journal-title":"Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1537-2995.2007.01089.x","article-title":"Platelet utilisation and the transfusion trigger: A prospective analysis","volume":"72","author":"Greeno","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0060|cit60","first-page":"271","article-title":"Preliminary report on a randomized study of prophylactic (P) vs. therapeutic (T) platelet transfusions","volume":"80","author":"Grossman","year":"1980","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.bmt.1705751","article-title":"Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML\/MDS patients receiving allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Gurkan","year":"2007","journal-title":"Bone Marrow Transplantation"},{"issue":"Supplement","key":"10.1002\/14651858.CD010983.pub2-BIB0062|cit62","first-page":"Abstract 330","article-title":"Safety of stringent prophylactic platelet transfusion (PT) policy for lymphoma patients treated by high dose chemotherapy (HDC) and autologous stem cell support. [20th Annual Meeting of the European Group for Bone Marrow Transplantation and 10th Meeting of the Nurses Group]","volume":"14","author":"Hardan","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0063|cit63","unstructured":"Harrup RA Kennedy JT Kiss J Daniels B Randomised blinded comparison of buffy coat plasma or T-sol supported platelet transfusions Haematology Society of Australia and New Zealand Annual Scientific Meeting Hobart; Tasmania October 1999"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0064|cit64","first-page":"349a","article-title":"A survival advantage in leukaemics receiving ABO identical platelets","volume":"78","author":"Heal","year":"1991","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0065|cit65","first-page":"348a","article-title":"The importance of ABO identical platelet transfusions","volume":"78","author":"Heal","year":"1991","journal-title":"Blood"},{"issue":"7 Supp 1","key":"10.1002\/14651858.CD010983.pub2-BIB0066|cit66","first-page":"215a","article-title":"A randomised trial of ABO identical versus ABO unmatched platelet transfusions","volume":"74","author":"Heal","year":"1989","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0609.1993.tb00150.x","article-title":"The role of ABO matching in platelet transfusion","volume":"50","author":"Heal","year":"1993","journal-title":"European Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0268-960X(03)00057-2","article-title":"Optimizing platelet transfusion therapy","volume":"18","author":"Heal","year":"2004","journal-title":"Blood Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199409083311001","article-title":"The role of the plasma from platelet concentrates in transfusion reactions","volume":"331","author":"Heddle","year":"1994","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1537-2995.2002.00094.x","article-title":"A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets","volume":"42","author":"Heddle","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1537-2995.2003.00418.x","article-title":"Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies","volume":"43","author":"Heddle","year":"2003","journal-title":"Transfusion"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1537-2995.2005.04233.x","article-title":"Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial","volume":"45","author":"Heddle","year":"2005","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1751-2824.2007.00093.x","article-title":"Controversy concerning platelet dose","volume":"2","author":"Heddle","year":"2007","journal-title":"ISBT Science Series, Vol 2, No 1: State of the Art Presentations"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1537-2995.2011.03181.x","article-title":"Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges","volume":"51","author":"Heddle","year":"2011","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0077|cit77","unstructured":"NCT00420914 Strategies for Transfusion of Platelets (SToP) http:\/\/clinicaltrials.gov\/show\/NCT00420914"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.1974.tb04558.x","article-title":"The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study","volume":"14","author":"Higby","year":"1974","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0079|cit79","unstructured":"ISRCTN01292427 Comparison of in vivo outcome following transfusion of dynamic light scattering-screened versus unscreened platelets in hematologic malignancy www.controlled-trials.com\/ISRCTN01292427"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0080|cit80","unstructured":"ISRCTN49080246 Platelet Process Improvement Project http:\/\/www.controlled-trials.com\/ISRCTN49080246"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0081|cit81","unstructured":"ISRCTN56366401 Platelet responsiveness and outcome from platelet transfusion - does inherent variation in donor platelet function affect the clinical efficacy of apheresis platelets? A randomised double blind single centre trial UK Clinical Research Network (UKCRN) http:\/\/www.controlled-trials.com\/ISRCTN56366401"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00024669-200605060-00004","article-title":"Chemotherapy-associated thrombocytopenia current and emerging management strategies","volume":"5","author":"Jelic","year":"2006","journal-title":"American Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1537-2995.2007.01160.x","article-title":"Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice","volume":"47","author":"Johansson","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1537-2995.2008.01914.x","article-title":"Transfusion efficacy of ABO major-mismatched platelets (PLTS) in children is inferior to that of ABO-identical platelets","volume":"91","author":"Julmy","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0085|cit85","first-page":"600","article-title":"Alloimmunization following apheresis platelets vs. pooled platelet concentrates. A prospective randomized study","volume":"21","author":"Kakaiya","year":"1981","journal-title":"Transfusion"},{"issue":"s3","key":"10.1002\/14651858.CD010983.pub2-BIB0086|cit86","first-page":"2A","article-title":"Clinical effectiveness and safety of pooled, random donor platelet concentrates, leucoreduced and stored up to seven days in either plasma or additive solution with and without pathogen reduction in hemato-oncological patients","volume":"49","author":"Kerkhoffs","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2010.08227.x","article-title":"Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction","volume":"150","author":"Kerkhoffs","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"12","key":"10.1002\/14651858.CD010983.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1046\/j.1537-2995.2000.40121457.x","article-title":"Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial","volume":"40","author":"Ackerman","year":"2000","journal-title":"Transfusion"},{"issue":"10s","key":"10.1002\/14651858.CD010983.pub2-BIB0089|cit89","first-page":"46S","article-title":"The effect of platelet dose on the outcome of prophylactic platelet transfusion","volume":"35","author":"Hermann","year":"1995","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0090|cit90","unstructured":"Klumpp T Herman JH Christman RA Russo RR Goldberg SL MacDonald JS The effect of platelet dose on the interval between platelet transfusions in patients undergoing bone marrow or peripheral blood stem cell transplantation Proceedings of American Society of Clinical Oncology (ASCO) 1995 536"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1537-2995.1999.39070674.x","article-title":"Clinical consequences of alterations in platelet dose: a prospective, randomized, double-blind trial","volume":"39","author":"Klumpp","year":"1999","journal-title":"Transfusion"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002770050206","article-title":"In-vivo evaluation of random donor platelet concentrates from pooled buffy coats","volume":"73","author":"Kluter","year":"1996","journal-title":"Annals of Hematology"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD010983.pub2-BIB0093|cit93","first-page":"P756","article-title":"A randomised trial of platelet transfusion policies after blood stem cell transplantation in young children: reduction of number of single platelet concentrate donors per child","volume":"31","author":"Lapierre","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190109057955","article-title":"Lowering the prophylactic platelet transfusion threshold: a prospective analysis","volume":"41","author":"Lawrence","year":"2001","journal-title":"Leukemia & Lymphoma"},{"issue":"Suppl","key":"10.1002\/14651858.CD010983.pub2-BIB0095|cit95","first-page":"20S","article-title":"Use of warmed single donor platelets in autologous bone marrow transplant patients","volume":"31","author":"Leach","year":"1991","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1537-2995.1989.29589284135.x","article-title":"ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial","volume":"29","author":"Lee","year":"1989","journal-title":"Transfusion"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010983.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03165104","article-title":"Management of bleeding disorders by prohemostatic therapy","volume":"76","author":"Levi","year":"2002","journal-title":"International Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pharmthera.2009.03.019","article-title":"Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence","volume":"123","author":"Lordkipanidze","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/tmrv.2003.50003","article-title":"The clinical implications of platelet transfusions associated with ABO or Rh[D) incompatibility","volume":"17","author":"Lozano","year":"2003","journal-title":"Transfusion Medicine Reviews"},{"issue":"Supp 2","key":"10.1002\/14651858.CD010983.pub2-BIB0100|cit100","first-page":"25A","article-title":"Frequency of prophylactic transfusion failure: a novel outcome to evaluate platelet components stored more than 5 days","volume":"50","author":"Lozano","year":"2010","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2141.2011.08635.x","article-title":"A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotsalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion","volume":"153","author":"Lozano","year":"2011","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0102|cit102","first-page":"295","article-title":"Effect of reducing prophylactic platelet transfusion dose on bleeding in thrombocytopenia patients","volume":"34","author":"Lu","year":"2011","journal-title":"International Journal of Blood Transfusion and Hematology"},{"issue":"S1","key":"10.1002\/14651858.CD010983.pub2-BIB0103|cit103","first-page":"310 (P-577)","article-title":"Effect of reducing prophylactic platelet transfusion dose on bleeding in thrombocytopenic patients","volume":"101","author":"Lu","year":"2011","journal-title":"Vox Sanguinis"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"708a","DOI":"10.1182\/blood.V104.11.2587.2587","article-title":"A meta-analysis to determine the risk of heparin induced thrombocytopenia (HIT) and isolated thrombocytopenia in prophylaxis studies comparing unfractionated heparin (UFH) and low molecular weight heparin (LMWH)","volume":"104","author":"Martel","year":"2004","journal-title":"Blood"},{"issue":"9S","key":"10.1002\/14651858.CD010983.pub2-BIB0105|cit105","first-page":"9A","article-title":"Fresh (1-2 day-old) vs. aged (4-5 day-old) INTERCEPT platelets and conventional platelets provide comparable count increments. However fresh platelets result in superior hemostasis: results of the SPRINT trial","volume":"43","author":"Benjamin","year":"2003","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0106|cit106","doi-asserted-by":"crossref","unstructured":"Corash L Lin JS Sherman CD Eiden J Determination of acute lung injury following repeated platelet transfusions Blood 2010 1014 20","DOI":"10.1182\/blood-2010-06-293399"},{"issue":"9S","key":"10.1002\/14651858.CD010983.pub2-BIB0107|cit107","first-page":"17S","article-title":"A platelet transfusion threshold of 20 x 109\/L compared to 10 x 109\/L is associated with increased pre-transfusion bleeding and increased platelet transfusions: results of the SPRINT study","volume":"42","author":"Goodnough","year":"2002","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010983.pub2-BIB0108|cit108","first-page":"110a","article-title":"Apheresis platelets treated with the INTERCEPT Blood System for pathogen inactivation provide platelet count increments and hemostasis comparable to conventional platelets","volume":"83","author":"Kluter","year":"2002","journal-title":"Vox Sanguinis"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-12-4443","article-title":"Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial","volume":"104","author":"McCullough","year":"2004","journal-title":"Blood"},{"issue":"109","key":"10.1002\/14651858.CD010983.pub2-BIB0110|cit110","first-page":"Abstract","article-title":"INTERCEPT platelets are hemostatically as effective as conventional platelet in the prophylaxis and treatment of bleeding: results of the SPRINT trial","volume":"83","author":"Murphy","year":"2002","journal-title":"Vox Sanguinis"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1537-2995.2005.00671.x","article-title":"Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light","volume":"46","author":"Murphy","year":"2006","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1537-2995.2006.00761.x","article-title":"Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial","volume":"46","author":"Pineda","year":"2006","journal-title":"Transfusion"},{"issue":"Pt 2","key":"10.1002\/14651858.CD010983.pub2-BIB0113|cit113","first-page":"141b","article-title":"INTERCEPT platelets (plts) and conventional plts provide comparable hemostatic response in thrombocytopenic patients: the SPRINT trial","volume":"11","author":"Slichter","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Snyder E McCullough J Slichter SJ Strauss RG Lopez-Plaza I Lin JS Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial Transfusion 2005 1864 75","DOI":"10.1111\/j.1537-2995.2005.00639.x"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010983.pub2-BIB0115|cit115","first-page":"Abstract","article-title":"Intercept platelets exhibit immunological refractoriness comparable to conventional platelets","volume":"89","author":"Strauss","year":"2004","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0116|cit116","doi-asserted-by":"crossref","unstructured":"Vesole D Stadtmauer E Goodnough LT Coutre S Howard F Lin JS Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the Phase III SPRINT trial of INTERCEPT pathogen inactivated platelets Biology of Blood and Bone Marrow Transplantation 2004 233","DOI":"10.1016\/j.bbmt.2003.12.166"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/jphs.93.381","article-title":"Platelets and platelet therapy","volume":"93","author":"McNicol","year":"2003","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/1097-0142(19880815)62:4<795::AID-CNCR2820620426>3.0.CO;2-7","article-title":"A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients","volume":"62","author":"Messerschmidt","year":"1988","journal-title":"Cancer"},{"issue":"12","key":"10.1002\/14651858.CD010983.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/j.1537-2995.2009.02347.x","article-title":"Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates","volume":"49","author":"Ambruso","year":"2009","journal-title":"Transfusion"},{"issue":"Suppl","key":"10.1002\/14651858.CD010983.pub2-BIB0120|cit120","first-page":"20A. Abstract N","article-title":"Clinical evaluation of Mirasol PRT treated apheresis platelets in thrombocytopenic patients","volume":"48","author":"Goodrich","year":"2008","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1537-2995.2010.02694.x","article-title":"A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology","volume":"50","author":"The Mirasol Clinical Evaluation Study Group","year":"2010","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajh.2830120406","article-title":"Indications for platelet transfusion in children with acute leukemia","volume":"12","author":"Murphy","year":"1982","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1986.tb02965.x","article-title":"Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization","volume":"62","author":"Murphy","year":"1986","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0124|cit124","first-page":"998","article-title":"Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000\/mL","volume":"83","author":"Navarro","year":"1998","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0125|cit125","unstructured":"NCT00699621 Platelet transfusion in acute intracerebral haemorrhage https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00699621"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0126|cit126","unstructured":"NCT01615146 Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot http:\/\/ClinicalTrials.gov\/show\/NCT01615146\u00a0\u00a0\u00a0\u00a0"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1537-2995.2007.01193.x","article-title":"Acute bleeding complications in patients after haematopoietic stem cell transplantation triggers of 10 x 109 and 20 x 109 per L","volume":"47","author":"Nevo","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V92.4.1448","article-title":"Platelet transfusion: a dose response study","volume":"92","author":"Norol","year":"1998","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0129|cit129","first-page":"1669","article-title":"The effects of infusion methods on platelet count, morphology, and corrected count increment in children with cancer: in vitro and in vivo studies","volume":"21","author":"Norville","year":"1994","journal-title":"Oncology Nursing Forum"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0130|cit130","first-page":"1789","article-title":"The effects of infusion rate on platelet outcomes and patient responses in children with cancer: an in vitro and in vivo study","volume":"24","author":"Norville","year":"1997","journal-title":"Oncology Nursing Forum"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1537-2995.1991.31791368333.x","article-title":"Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components: A randomized trial","volume":"31","author":"Oksanen","year":"1991","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1423-0410.1994.tb01273.x","article-title":"Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat","volume":"67","author":"Oksanen","year":"1994","journal-title":"Vox Sanguinis"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MPH.0b013e3181b794d0","article-title":"Evaluation of the effects of different transfusion trigger levels during the treatment of childhood acute lymphoblastic leukemia","volume":"31","author":"Paananen","year":"2009","journal-title":"Journal of Pediatric Haematology\/Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0134|cit134","first-page":"343","article-title":"Comparative clinical studies of platelet concentrates: Effects on clinical outcome and the use of healthcare resources","volume":"17","author":"Pamphilon","year":"1996","journal-title":"Transfusion Science"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0135|cit135","first-page":"231","article-title":"Pharmacological alternatives to blood transfusion: what is new about?","volume":"122","author":"Paramo","year":"2004","journal-title":"Medicina Clinica"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0136|cit136","first-page":"139","article-title":"Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?","volume":"2","author":"Poon","year":"2003","journal-title":"Current Hematology Reports"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tracli.2008.01.002","article-title":"National comparative audit of the use of platelet transfusions in the UK","volume":"14","author":"Qureshi","year":"2007","journal-title":"Transfusion Clinique Et Biologique"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0138|cit138","first-page":"11","article-title":"Dose of prophylactic platelet transfusions did not affect bleeding incidence or severity","volume":"152","author":"Rabinowitz","year":"2010","journal-title":"ACP Journal Club"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004226.pub2","article-title":"Antenatal interventions for fetomaternal alloimmune thrombocytopenia","author":"Rayment","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MCG.0b013e31823d33e3","article-title":"Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review","volume":"46","author":"Razzaghi","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"Abstract No. LE","DOI":"10.2450\/2009.0013-09","article-title":"Pathogen inactivated platelets and prevention of immunological adverse reactions: the Italian Platelet Technology Assessment Study (IPTAS)","volume":"7, Suppl 1: 11t","author":"Rebulla","year":"2009","journal-title":"Blood Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000658-198601000-00008","article-title":"Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study","volume":"203","author":"Reed","year":"1986","journal-title":"Annals of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00008480-200302000-00004","article-title":"Thrombocytopenia in the newborn","volume":"15","author":"Roberts","year":"2003","journal-title":"Current Opinion in Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1537-2995.1973.tb05490.x","article-title":"Prophylactic platelet transfusion in children with acute leukemia: A dose response study","volume":"13","author":"Roy","year":"1973","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platelet transfusion policy allowing long term support of outpatients with severe aplastic anaemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0146|cit146","first-page":"1025","article-title":"Prevention of hemorrhage occurring in patients with leukemia","volume":"92","author":"Sakakura","year":"2003","journal-title":"Zassh (Nippon-Naika-Gakkai-Zasshi)"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF03018577","article-title":"Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003","volume":"52","author":"Samama","year":"2005","journal-title":"Canadian Journal of Anaesthesia"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0148|cit148","first-page":"447","article-title":"Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003","volume":"72","author":"Samama","year":"2006","journal-title":"Minerva Anestesiologica"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V62.4.815.815","article-title":"A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia","volume":"62","author":"Schiffer","year":"1983","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0150|cit150","first-page":"(Abstract 2789)","article-title":"Increasing dose improves the platelet transfusions: results of a prospective multicentre randomised study","volume":"100","author":"Sensebe","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2004-05-1841","article-title":"The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study","volume":"105","author":"Sensebe","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0609.1992.tb00035.x","article-title":"A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients","volume":"49","author":"Shanwell","year":"1992","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1537-2995.2009.02273.x","article-title":"ABO-identical versus non-identical platelet transfusion: a systematic review","volume":"49","author":"Shehata","year":"2009","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.hoc.2007.06.001","article-title":"Acquired platelet dysfunction","volume":"21","author":"Shen","year":"2007","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"5 Supp","key":"10.1002\/14651858.CD010983.pub2-BIB0155|cit155","first-page":"285A","article-title":"A prospective randomized study of platelet support in leukemic patients","volume":"72","author":"Singer","year":"1988","journal-title":"Transfusion"},{"issue":"8223","key":"10.1002\/14651858.CD010983.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(81)92626-X","article-title":"Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia","volume":"1","author":"Sintnicolaas","year":"1981","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0157|cit157","first-page":"684","article-title":"Comparison of prophylactic and therapeutic single-donor platelet transfusions in patients with acute leukaemia","volume":"50","author":"Sintnicolaas","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.V85.3.824.bloodjournal853824","article-title":"Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study","volume":"85","author":"Sintnicolaas","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0159|cit159","first-page":"Abstract","article-title":"Prospective randomized transfusion trial to directly compare fresh and stored apheresis platelets (AP) and pooled random donor platelet concentrates (PC) in thrombocytopenic patients","volume":"92","author":"Slichter","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1537-2995.2006.00791.x","article-title":"Platelets photochemically treated with amotsalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia","volume":"46","author":"Slichter","year":"2006","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Evidence-based platelet transfusion guidelines","volume":"2007","author":"Slichter","year":"2007","journal-title":"Hematology\/the Education Program of the American Society of Hematology"},{"issue":"Supplement","key":"10.1002\/14651858.CD010983.pub2-BIB0163|cit163","first-page":"188A","article-title":"Cost tradeoffs of low-, medium-, and high-dose platelet transfusions","volume":"53","author":"Assman","year":"2013","journal-title":"Transfusion"},{"issue":"S3","key":"10.1002\/14651858.CD010983.pub2-BIB0164|cit164","first-page":"19A","article-title":"Increased incidence of Grade 2 and higher bleeding in pediatric PLADO trial patients","volume":"49","author":"Josephson","year":"2009","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2011-11-389569","article-title":"Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia","volume":"120","author":"Josephson","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/trf.12791","article-title":"Transfusion-related adverse events in the platelet dose study","volume":"55","author":"Kaufman","year":"2015","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0167|cit167","unstructured":"NCT00128713 Optimal platelet dose strategy for management of thrombocytopenia http:\/\/clinicaltrials.gov\/show\/NCT00128713"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0170|cit168","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.20090","article-title":"Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients","volume":"21","author":"Slichter","year":"2006","journal-title":"Journal of Clinical Apheresis"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0168|cit169","doi-asserted-by":"crossref","first-page":"Abstract 285","DOI":"10.1182\/blood.V112.11.285.285","article-title":"Effects of prophylactic platelet (Plt) dose on transfusion (Tx) outcomes (PLADO trial).","volume":"112","author":"Slichter","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0169|cit170","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of haemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"Supplement","key":"10.1002\/14651858.CD010983.pub2-BIB0171|cit171","first-page":"3A","article-title":"The effect of platelet characteristics on the platelet increment and HLA alloimmunization in hypoproliferative thrombocytopenia","volume":"50","author":"Triulzi","year":"2010","journal-title":"Transfusion"},{"issue":"23","key":"10.1002\/14651858.CD010983.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1182\/blood-2011-11-393165","article-title":"The impact of platelet transfusion characteristics on post-transfusion platelet increments and clinical bleeding in patients with hypo-proliferative thrombocytopenia","volume":"119","author":"Triulzi","year":"2012","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0173|cit173","first-page":"227","article-title":"Effects of platelet (Plt) dose on transfusion outcomes","volume":"22","author":"Slichter","year":"2012","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(78)90505-6","article-title":"Platelet prophylaxis in acute non-lymphoblastic leukemia","volume":"1 (8058)","author":"Solomon","year":"1978","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00005237-200307000-00003","article-title":"Alloimmune thrombocytopenia in the fetus: current management theories","volume":"17","author":"Sosa","year":"2003","journal-title":"The Journal of Perinatal & Neonatal Nursing"},{"issue":"8","key":"10.1002\/14651858.CD010983.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1537-2995.2004.03322.x","article-title":"Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes","volume":"44","author":"Spiess","year":"2004","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/trf.12697","article-title":"Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial","volume":"54","author":"Campbell","year":"2014","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0178|cit178","unstructured":"ISRCTN08758735 A randomised controlled trial of prophylactic versus no-prophylactic platelet transfusions in patients with haematological malignancies http:\/\/www.controlled-trials.com\/ISRCTN08758735"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0179|cit179","first-page":"46","article-title":"Objective assessment of bleeding in patients with haematological malignancies in an international study of platelet transfusions - how was consistency achieved [31st Annual Scientific Meeting of the British Blood Transfusion Society, Birmingham]","volume":"23","author":"Powter","year":"2013","journal-title":"Transfusion Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tmrv.2009.11.002","article-title":"Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions","volume":"24","author":"Stanworth","year":"2010","journal-title":"Transfusion Medicine Reviews"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD010983.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"Abstract 1","DOI":"10.1182\/blood.V120.21.1.1","article-title":"The effect of a no-prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe thrombocytopenia (TOPPS trial). A randomized controlled, non-inferiority trial","volume":"120","author":"Stanworth","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/trf.12646","article-title":"Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial","volume":"54","author":"Stanworth","year":"2014","journal-title":"Transfusion"},{"issue":"19","key":"10.1002\/14651858.CD010983.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3324\/haematol.2014.118075","article-title":"Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis","volume":"100","author":"Stanworth","year":"2015","journal-title":"Haematologica"},{"issue":"21","key":"10.1002\/14651858.CD010983.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V124.21.1551.1551","article-title":"Risk factors for bleeding: A modelling analysis of the TOPPS randomized controlled trial of prophylactic platelet transfusion","volume":"124","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010983.pub2-BIB0186|cit186","first-page":"Abstract","article-title":"A dose response study of platelet transfusion: comparison between triple dose apheresis platelet transfusion and three split standard transfusions","volume":"87","author":"Steffens","year":"2002","journal-title":"Haematologica"},{"issue":"12","key":"10.1002\/14651858.CD010983.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.0041-1132.2004.04378.x","article-title":"Low-dose prophylactic platelet transfusions: Time for further study, but too early for routine clinical practice","volume":"44","author":"Strauss","year":"2004","journal-title":"Transfusion"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0188|cit188","first-page":"499","article-title":"Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions","volume":"12","author":"Strauss","year":"2005","journal-title":"Current Opinion in Hematology"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0609.1996.tb01382.x","article-title":"Transfusion of platelet concentrates - clinical evaluation of two preparations","volume":"57","author":"Strindberg","year":"1996","journal-title":"European Journal of Haematology"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1537-2995.2000.40070794.x","article-title":"A comparison of prestorage WBC-reduced whole blood derived platelets in autologous progenitor cell transplant","volume":"40","author":"Sweeney","year":"2000","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-7963(03)00018-X","article-title":"Prophylactic platelet transfusions: which dose is the best dose? A review of the literature","volume":"17","author":"Tinmouth","year":"2003","journal-title":"Transfusion Medicine Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010983.pub2-BIB0192|cit192","first-page":"8","article-title":"A randomised phase II trial of low dose and standard dose platelet transfusions during induction therapy for acute leukemia or autologous stem cell transplantation","volume":"83","author":"Tinmouth","year":"2002","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.0041-1132.2004.04118.x","article-title":"Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor transplant and patients with acute leukaemia: a randomized controlled trial with a sequential Bayesian design","volume":"44","author":"Tinmouth","year":"2004","journal-title":"Transfusion Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.thromres.2009.06.009","article-title":"Management of bleeding and of invasive procedures in patients with platelet disorders and\/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)","volume":"125","author":"Tosetto","year":"2009","journal-title":"Thrombosis Research"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1537-2995.2003.00529.x","article-title":"Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial","volume":"43","author":"Enright","year":"2003","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"The Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(02)09090-6","article-title":"Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study","volume":"359","author":"Vadhan-Raj","year":"2002","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V77.1.201.201","article-title":"Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial","volume":"77","author":"Marwijk","year":"1991","journal-title":"Blood"},{"issue":"4 Supp 11","key":"10.1002\/14651858.CD010983.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0037-1963(01)90123-4","article-title":"Design of clinical trials to evaluate the efficacy of platelet transfusion: the euroSPRITE trial for components treated with Helinx technology","volume":"38","author":"Cazenave","year":"2001","journal-title":"Seminars in Hematology"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010983.pub2-BIB0201|cit201","first-page":"Various","article-title":"INTERCEPT buffy coat platelets (IPC) are effective during multiple episodes of thrombocytopenia: the EUROSPRITE trial","volume":"8","author":"Cazenave","year":"2001","journal-title":"Transfusion Clinique et Biologique"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010983.pub2-BIB0202|cit202","first-page":"100s","article-title":"Results of the EUROSPRITE phase III trial: INTERCEPT buffy coat platelet concentrates (IPC) provide effective hemostasis for thrombocytopenic (TCP) patients (PTS)","volume":"8","author":"Ljungman","year":"2001","journal-title":"Transfusion Clinique et Biologique"},{"issue":"Supp 1","key":"10.1002\/14651858.CD010983.pub2-BIB0203|cit203","first-page":"100","article-title":"The EUROSPRITE phase III trial of INTERCEPT buffy coat platelet concentrates (IPC) demonstrates IPC are safe when transfused to thrombocytopenic (TCP) patients (PTS)","volume":"8","author":"Pamphilon","year":"2001","journal-title":"Transfusion Clinique et Biologique"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood-2002-03-0932","article-title":"Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial","volume":"101","author":"Rhenen","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2007.02481.x","article-title":"The effect of fibrinogen concentrate on thrombocytopenia","volume":"5","author":"Velik-Salchner","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.transci.2008.05.013","article-title":"Platelet transfusions in clinical practice at a multidisciplinary hospital in North India","volume":"39","author":"Verma","year":"2008","journal-title":"Transfusion and Apheresis Science"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10 x 109\/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukaemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010983.pub2-BIB0208|cit208","first-page":"A140","article-title":"The 10\/NL trigger for prophylactic platelet transfusion in AML: a prospective comparative multicenter study","volume":"70","author":"Wandt","year":"1995","journal-title":"Annals of Hematology"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V106.11.428.428","article-title":"Routine prophylactic platelet transfusions are not necessary in patients with acute myeloid leukaemia. A therapeutic transfusion strategy is safe","volume":"106","author":"Wandt","year":"2005","journal-title":"Blood"},{"issue":"(Abstract 2782)","key":"10.1002\/14651858.CD010983.pub2-BIB0210|cit210","first-page":"706a","article-title":"New strategy for platelet transfusion for patients with acute myeloid leukaemia: routine prophylactic transfusion replaced by therapeutic transfusion","volume":"100","author":"Wandt","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1705246","article-title":"A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation","volume":"37","author":"Wandt","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"38","key":"10.1002\/14651858.CD010983.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1055\/s-0030-1263332","article-title":"Indication for platelet transfusion in patients with haematological\u00a0disease: less is more. [German]","volume":"135","author":"Wandt","year":"2010","journal-title":"Deutsche Medizinische Wochenschrift\u00a0\u00a0\u00a0\u00a0\u00a0"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0213|cit213","unstructured":"NCT00521664 A trial comparing a prophylactic with a therapeutic platelet strategy in two groups http:\/\/clinicaltrials.gov\/show\/NCT00521664"},{"issue":"21","key":"10.1002\/14651858.CD010983.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V124.21.3686.3686","article-title":"Consolidation therapy is associated with significantly lower bleeding risk compared to induction therapy in patients with acute myeloid leukemia","volume":"124","author":"Schaefer-Eckart","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010983.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"Abstract","DOI":"10.1182\/blood.V108.11.577.577","article-title":"Interim analysis of a prospective randomised study comparing a therapeutic platelet strategy with the prophylactic platelet transfusion standard in patients after autologous peripheral stem cell transplantation (ASCT)","volume":"108","author":"Schaefer-Eckart","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0217|cit216","first-page":"Abstract","article-title":"Experience with a therapeutic platelet transfusion strategy in patients with acute myeloid leukemia. Final results of a randomized multicenter study comparing a prophylactic with a therapeutic transfusion strategy","volume":"33","author":"Wandt","year":"2010","journal-title":"Onkologie"},{"issue":"Supplement","key":"10.1002\/14651858.CD010983.pub2-BIB0218|cit217","first-page":"Abstract","article-title":"Experience with a therapeutic platelet transfusion strategy in acute myeloid leukaemia: Preliminary results of a randomised multicenter study after enrolment of 175 patients","volume":"11","author":"Wandt","year":"2009","journal-title":"Blood"},{"issue":"9850","key":"10.1002\/14651858.CD010983.pub2-BIB0219|cit218","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0216|cit219","first-page":"S23","article-title":"A therapeutic platelet transfusion strategy without routine prophylactic transfusion is feasible and safe and reduces platelet transfusion numbers significantly: final analysis of a randomised study after high-dose chemotherapy and PBSCT","volume":"43 Supp 1","author":"Wandt","year":"2009","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0220|cit220","first-page":"Abstract 286","article-title":"Therapeutic platelet transfusion strategy without routine prophylactic transfusion is feasible and safe and reduces platelet transfusion numbers significantly: preliminary analysis of a randomized study in patients after high dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"112","author":"Wandt","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajh.10119","article-title":"Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial","volume":"70","author":"Wang","year":"2002","journal-title":"American Journal of Hematology"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0222|cit222","first-page":"482","article-title":"Using evidence-based guideline for prophylactic platelet transfusion in patient with myelodysplastic syndrome","volume":"5","author":"Wang","year":"2005","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00063-009-1070-2","article-title":"Low levels of prothrombin (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters","volume":"104","author":"Weigand","year":"2009","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V83.10.3028.3028","article-title":"Bedside filtration of blood products in the prevention of HLA alloimmunization: A prospective randomized study. Alloimmunization Study Group","volume":"83","author":"Williamson","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0031-3955(02)00026-3","article-title":"New approaches to hematopoietic cell transplantation for hematological diseases in children","volume":"49","author":"Woodard","year":"2002","journal-title":"Pediatric Clinics of North America"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0226|cit226","first-page":"27","article-title":"Platelet transfusion practice in a tertiary care hospital","volume":"13","author":"Zahur","year":"2002","journal-title":"Medical Forum Monthly"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOH.0000000000000087","article-title":"Prophylactic platelet transfusions: should they be a treatment of the past?","volume":"21","author":"Zeller","year":"2014","journal-title":"Current Opinion in Hematology"},{"issue":"6","key":"10.1002\/14651858.CD010983.pub2-BIB0228|cit228","first-page":"568","article-title":"Clinical assessment of preventing febrile nonhemolytic transfusion reaction by leucocyte depleted blood transfusion","volume":"10","author":"Zhao","year":"2002","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0229|cit229","unstructured":"Zumberg MS Rosario ML Pollock BH Nejame CF Allen LS Boyette R A prospective randomized trial of prophylactic platelet transfusion\u00a0d bleeding incidence in hematopoietic stem cell transplant (HSCT) recipients: 10,000\u00b5L vs. an 20,000 \u00b5L threshold [abstract] 37th Annual Meeting of the American Society of Clinical Oncology, 2001\u00a0May 12-15; San Fransisco San Francisco American Society of Clinical Oncology 2001"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000\/\u00b5L versus 20,000\/\u00b5L trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/07357909009017560","article-title":"Comprehensive criteria for assessing therapy-induced toxicity","volume":"8","author":"Ajani","year":"1990","journal-title":"Cancer Investigation"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2003.04468.x","article-title":"Guidelines for the use of platelet transfusions","volume":"122","author":"British Committee for Standards in Haematology (BCSH)","year":"2003","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2004.04815.x","article-title":"Transfusion guidelines for neonates and older children","volume":"124","author":"British Committee for Standards in Haematology (BCSH)","year":"2004","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.2009.07840.x","article-title":"Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill","volume":"147","author":"Benson","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V81.6.1411.1411","article-title":"Platelet transfusions: the 20,000\/\u03bcL trigger","volume":"81","author":"Beutler","year":"1993","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12026-009-8106-9","article-title":"The platelet as an immune cell - CD40 ligand and transfusion immune modulation","volume":"45","author":"Blumberg","year":"2009","journal-title":"Immunology Research"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0237|cit237","first-page":"372","article-title":"Platelet concentrates. Cross-sectional guidelines for therapy with blood components and plasma derivatives","volume":"36","author":"The Board of the German Medical Association on the Recommendation of the Scientific Advisory Board","year":"2009","journal-title":"Transfusion Medicine and Hemotherapy"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0238|cit238","volume-title":"The 2011 Annual SHOT Report","author":"Bolton-Maggs PHB (Ed) and H Cohen on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group","year":"2012"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1200\/JCO.2010.31.4310","article-title":"Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial","volume":"29","author":"Burnett","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0240|cit240","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009072","article-title":"Pathogen-reduced platelets for the prevention of bleeding","author":"Butler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0241|cit241","unstructured":"Cancer Research UK Percentage change in European age-standardised three year average incidence rates, males, UK, 1991-2001 and 2008-2010 Cancer Research UK statistics at http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0242|cit242","unstructured":"CDC (Centers for Disease Control and Prevention) United States Cancer Statistics National Program of Cancer Registries (NPCR) http:\/\/www.cdc.gov\/cancer\/npcr\/"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.bjc.6601696","article-title":"Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001","volume":"90","author":"Coleman","year":"2004","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomized trials of platelet transfusion triggers","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin","volume":"111","author":"Serna","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0246|cit246","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1910.04330140029009","article-title":"The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of 3 cases of hemorrhagic disease relieved by transfusion","volume":"55","author":"Duke","year":"1910","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.2010.08483.x","article-title":"Platelet transfusions for patients with haematological malignancies: who needs them?","volume":"154","author":"Estcourt","year":"2011","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2012.01627.x","article-title":"Platelet transfusions in haematology patients: are we using them appropriately?","volume":"103","author":"Estcourt","year":"2012","journal-title":"Vox Sanguinis"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/trf.12058","article-title":"The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions","volume":"53","author":"Estcourt","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0251|cit251","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010984","article-title":"Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0252|cit252","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010982","article-title":"Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0253|cit253","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010981","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0254|cit254","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/trf.12441","article-title":"Does bleeding affect patient reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review","volume":"54","author":"Estcourt","year":"2014","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0197-2456(89)90026-3","article-title":"Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials","volume":"10","author":"Freedman","year":"1989","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","article-title":"The quantitative relation between platelet count and hemorrhage in patients with acute leukaemia","volume":"266","author":"Gaydos","year":"1962","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0258|cit258","unstructured":"McMaster University GRADEpro 2015"},{"issue":"16","key":"10.1002\/14651858.CD010983.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1309\/91PR-E4G6-XBAF-N8DY","article-title":"An interlaboratory study of a candidate reference method for platelet counting","volume":"115","author":"Harrison","year":"2001","journal-title":"American Journal of Clinical Pathology"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1537-2995.2008.01731.x","article-title":"Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review","volume":"48","author":"Heddle","year":"2008","journal-title":"Transfusion"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/9781444311761.ch6","article-title":"Investigation of acute transfusion reactions","volume-title":"Practical Transfusion Medicine","author":"Heddle","year":"2009"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0264|cit264","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0265|cit265","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0266|cit266","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0267|cit267","volume-title":"The 2010 Annual SHOT Report","author":"Knowles","year":"2011"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1537-2995.2004.03153.x","article-title":"Measurement of bleeding severity: a critical review","volume":"44","author":"Koreth","year":"2004","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/trf.12943","article-title":"Platelet transfusion: a systematic review of the clinical evidence","volume":"55","author":"Kumar","year":"2015","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0270|cit270","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0271|cit271","volume-title":"The National Blood Authority\u2019s Patient Blood Management Guideline: Module 3 - Medical","author":"National Blood Authority","year":"2012"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0272|cit272","unstructured":"Office for National Statistics Cancer incidence and mortality tables and charts http:\/\/www.ons.gov.uk\/ons\/index.html"},{"issue":"24","key":"10.1002\/14651858.CD010983.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2012.66","article-title":"The EBMT activity survey: 1990-2010","volume":"47","author":"Passweg","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3324\/haematol.2009.008649","article-title":"Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission","volume":"94","author":"Patel","year":"2009","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0276|cit276","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/trf.12175","article-title":"Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review","volume":"53","author":"Pavenski","year":"2013","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-3148.2010.01037.x","article-title":"Screening of platelet for bacterial contamination at the Welsh Blood Service","volume":"21","author":"Pearce","year":"2011","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0278|cit278","first-page":"17","article-title":"An audit of use and wastage in the north west of England and North Wales: where have all the platelets gone?","volume":"34","author":"Pendry","year":"2011","journal-title":"Blood and Transplant Matters"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","article-title":"Diagnostic and pathogenetic considerations in transfusion-related acute lung injury","volume":"25","author":"Popovsky","year":"1985","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0280|cit280","first-page":"351","article-title":"Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England","volume":"4","author":"Rachet","journal-title":"The Lancet Oncology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0281|cit281","unstructured":"The Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/09537100903388359","article-title":"Effect of beta-blockers, Ca2+antagonists, and benzodiazepines on bleeding incidence in patients with chemotherapy induced thrombocytopenia","volume":"21","author":"Rysler","year":"2010","journal-title":"Platelets"},{"issue":"1","key":"10.1002\/14651858.CD010983.pub2-BIB0283|cit283","doi-asserted-by":"publisher","first-page":"e8933","DOI":"10.1371\/journal.pone.0008933","article-title":"The average body surface area of adult cancer patients in the UK: a multicentre retrospective study","volume":"5","author":"Sacco","year":"2010","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0285|cit285","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2004.05352.x","article-title":"Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion","volume":"128","author":"Segal","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2002-03-0958","article-title":"Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors","volume":"101","author":"Silliman","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0308-2261(21)00047-3","article-title":"Thrombocytopenia: mechanisms and management of defects in platelet production","volume":"7","author":"Slichter","year":"1978","journal-title":"Clinical Haematology"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.me.31.020180.002453","article-title":"Controversies in platelet transfusion therapy","volume":"31","author":"Slichter","year":"1980","journal-title":"Annual Reviews of Medicine"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tmrv.2009.11.002","article-title":"Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions","volume":"24","author":"Stanworth","year":"2010","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0292|cit292","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention . Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD010983.pub2-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1046\/j.1537-2995.2002.00203.x","article-title":"Blood collection and transfusion in the United States in 1997","volume":"42","author":"Sullivan","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0294|cit294","volume-title":"The 2009 Annual SHOT Report","author":"Taylor","year":"2010"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0295|cit295","doi-asserted-by":"crossref","unstructured":"Tierney JF Stewart LA Ghersi D Burdett S Sydes MR Practical methods for incorporating summary time-to-event data into meta-analysis Trials 2007 10.1186\/1745-6215-8-16","DOI":"10.1186\/1745-6215-8-16"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0296|cit296","article-title":"Chapter 18: Platelet transfusion, alloimmunization and management of platelet refractoriness","volume-title":"Canadian Blood Services","author":"Tinmouth","year":"2007"},{"issue":"2","key":"10.1002\/14651858.CD010983.pub2-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.transci.2009.07.005","article-title":"Platelet utilization in the developing world: strategies to optimize platelet transfusion practices","volume":"41","author":"Verma","year":"2009","journal-title":"Transfusion and Apheresis Science"},{"key":"10.1002\/14651858.CD010983.pub2-BIB0298|cit298","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"issue":"7","key":"10.1002\/14651858.CD010983.pub2-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/09537104.2013.843072","article-title":"Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study","volume":"25","author":"Zisk","year":"2014","journal-title":"Platelets"},{"issue":"5","key":"10.1002\/14651858.CD010983.pub2-BIB0300|cit300","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004269.pub3","article-title":"Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation","author":"Estcourt","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010983.pub2-BIB0301|cit301","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010983","article-title":"Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation","author":"Estcourt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010983.pub2-BIB0302|cit302","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004269.pub2","article-title":"Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation","author":"Stanworth","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010983.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T14:41:32Z","timestamp":1718203292000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010983.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":302,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010983.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,18]]}}}